H&R GmbH & Co. KGaA (FRA:2HRA)

Market Cap	183.88M
Revenue (ttm)	1.36B
Net Income (ttm)	11.05M
Shares Out	n/a
EPS (ttm)	0.29
PE Ratio	16.64
Forward PE	n/a
Dividend	0.10 (2.03%)
Ex-Dividend Date	May 28, 2025

Volume	2,971
Average Volume	23,612
Open	4.930
Previous Close	4.940
Day's Range	4.930 - 4.940
52-Week Range	3.230 - 5.040
Beta	n/a
RSI	62.02
Earnings Date	Aug 15, 2025

About H&R GmbH & Co. KGaA

H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts in Europe, Africa, Asia, and internationally. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes...

• Industry: Chemicals and Allied Products
• Founded: 2016
• Employees: 1,705
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2HRA

Financial Performance

In 2024, H&R GmbH & Co. KGaA's revenue was 1.35 billion, a decrease of -1.06% compared to the previous year's 1.36 billion. Earnings were 10.62 million, an increase of 0.63%.